Back to search
Vulvar Cancer Stage I
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Vulvar Cancer Stage I trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Vulvar Cancer Stage I trials you may qualify forThis study is an open label, prospective, experimental, randomised clinical trial. The primary aim of this study is to determine whether it is feasible to rando…
This phase I trial studies the side effects and best dose of nelfinavir when given together with cisplatin and external beam radiation therapy in treating patie…
A multicenter, open label, single arm dose escalation phase I study to evaluate the safety, tolerability, and efficacy of HRYZ-T101 injection for HPV18 positive…
The goal of this study is to test the maximum tolerated dose of ACU-D1 in HIV-positive people with HPV-associated vulvar and perianal lesions. The main question…
Background: More than 30,000 cases of human papillomavirus (HPV) associated cancers occur annually in the United States. When these cancers spread, they do not…
Background: Often, metastatic human papillomavirus (HPV) associated cancers cannot be cured. They also do not respond well to treatment. Some forms of colon ca…